A review of the key issues associated with the commercialization of biobanks
about
Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital eraAttitudes of research participants and the general public towards genomic data sharing: a systematic literature reviewScientists' perspectives on consent in the context of biobanking research.Samples and data accessibility in research biobanks: an explorative surveyNewspaper coverage of biobanksDe-identified genomic data sharing: the research participant perspective.Engaging a state: Facebook comments on a large population biobank.Closure of a human tissue biobank: individual, institutional, and field expectations during cycles of promise and disappointmentDevelopments in biospecimen research.Transparency of Biobank Access in Canada: An Assessment of Industry Access and the Availability of Information on Access Policies and Resulting Research.Ethically sustainable governance in the biobanking of eggs and embryos for research.Genes, cells, and biobanks: Yes, there's still a consent problem.Locating Biobanks in the Canadian Privacy Maze.Identifying public expectations of genetic biobanks.The challenges of the expanded availability of genomic information: an agenda-setting paper.Consent, ethics and genetic biobanks: the case of the Athlome project.Children, Biological Samples, and Broad Consent.Biobanking from the patient perspective.Encouraging Participation And Transparency In Biobank Research
P2860
Q26741059-4BB8E373-AFD3-4B00-8041-730CC23C217FQ27008350-F49B3FAC-A1CA-48B3-A0C0-2AA9A688FEC9Q27325073-D073BAA5-AAEA-48A4-A1EE-68A96EC84FD3Q28603135-5ACD5E5D-067E-422A-BB8D-80E3538AE06EQ28654959-19F90B31-18AA-42D7-BEEF-8AF248E443FCQ33870461-6C2DF925-0E50-4936-A630-A62F3F643A72Q33870471-25EA9AA0-43A6-4217-A5E5-51C88A3DAC32Q36388725-755363C9-B6D1-492E-BF81-03EDB9A3F16DQ38390425-13CAA17C-9A6F-463E-890B-932588033B4BQ38619680-658F10AE-C4EA-400A-B09D-CA9F357D4037Q38681963-9CBF1AD7-5AA8-4C7E-802B-1238422FF770Q38696390-E0243932-327E-4BCE-BC14-B5394B7DB496Q39713938-66E3444D-C83E-4E83-82FF-F16A4CAF462AQ40105745-E9543510-7A4A-4C7B-8600-2D5808F81DDCQ42693470-468CCA76-C2A9-40CD-B48C-097765F87AC9Q45951505-52F35C98-1064-42EA-8D7C-31E6520ABBBFQ47980592-30C101DD-E1F5-494D-A0A7-48648AE29B31Q51101144-2B49BE1F-611A-482F-B925-6F92174F157BQ57172257-0E03827D-01CD-44FF-B8C4-8EA1F231CD0D
P2860
A review of the key issues associated with the commercialization of biobanks
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A review of the key issues associated with the commercialization of biobanks
@ast
A review of the key issues associated with the commercialization of biobanks
@en
A review of the key issues associated with the commercialization of biobanks
@nl
type
label
A review of the key issues associated with the commercialization of biobanks
@ast
A review of the key issues associated with the commercialization of biobanks
@en
A review of the key issues associated with the commercialization of biobanks
@nl
prefLabel
A review of the key issues associated with the commercialization of biobanks
@ast
A review of the key issues associated with the commercialization of biobanks
@en
A review of the key issues associated with the commercialization of biobanks
@nl
P2093
P50
P3181
P356
P1476
A review of the key issues associated with the commercialization of biobanks
@en
P2093
Allan Becker
Amy McGuire
Chris Scott
Daryl Pullman
Eric Meslin
Helen Wallace
Herbert Gottweis
John Lynch
Judy Illes
Kathryn Calder
P304
P3181
P356
10.1093/JLB/LST004
P407
P50
P577
2014-03-01T00:00:00Z